IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 8437 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

RESEARCH ARTICLE

Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome

Efe Edem, Kocayigit Ibrahim, Turker Pabuccu Mustafa, Murat Kucukukur, Erkan Alpaslan, Sedat Tas, Alper Cil, Necati Aksoy Murat, Gokhan Vural Mustafa, Bahri Akdeniz

Year : 2016| Volume: 48| Issue : 4 | Page no: 355-359

   This article has been cited by
 
1 Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y12 Inhibitors
Patricia P. Wadowski, Joseph Pultar, Constantin Weikert, Beate Eichelberger, Maximilian Tscharre, Renate Koppensteiner, Simon Panzer, Thomas Gremmel
Journal of Cardiovascular Pharmacology and Therapeutics. 2022; 27: 1074248422
[Pubmed]  [Google Scholar] [DOI]
2 Novel Predictors of Future Vascular Events in Post-stroke Patients—A Pilot Study
Diana Schrick, Erzsebet Ezer, Margit Tokes-Fuzesi, Laszlo Szapary, Tihamer Molnar
Frontiers in Neurology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
3 The Prognostic Significance of Neutrophil to Lymphocyte Ratio (NLR), Monocyte to Lymphocyte Ratio (MLR) and Platelet to Lymphocyte Ratio (PLR) on Long-Term Survival in Off-Pump Coronary Artery Bypass Grafting (OPCAB) Procedures
Tomasz Urbanowicz, Anna Olasinska-Wisniewska, Michal Michalak, Michal Rodzki, Anna Witkowska, Ewa Straburzynska-Migaj, Bartlomiej Perek, Marek Jemielity
Biology. 2021; 11(1): 34
[Pubmed]  [Google Scholar] [DOI]
4 Risk Factors of Recurrent Ischemic Events after Acute Noncardiogenic Ischemic Stroke
Limin Zhang, Xingang Li, Dongzhi Wang, Hong Lv, Xuezhong Si, Xiao Li, Yuehong Sun, Dan Wang, Kelin Chen, Xixiong Kang, Xin Lou, Guojun Zhang, Ning Ma
Current Pharmaceutical Design. 2020; 25(45): 4827
[Pubmed]  [Google Scholar] [DOI]
5 Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor
Monica Verdoia, Matteo Nardin, Rocco Gioscia, Federica Negro, Marco Marcolongo, Harry Suryapranata, Elvin Kedhi, Giuseppe De Luca
Vascular Pharmacology. 2020; 132: 106765
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow